Optimal Clinical Trials (North)

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials
• Asthma1 trial
• Coeliac disease1 trial
• Vitiligo1 trial

Phase

• Phase 23 trials
• Phase 11 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Evommune, Inc.1 trial
• Forte Biosciences, Inc.1 trial
• Prana Therapies Inc1 trial
• Takeda1 trial
• Teva Branded Pharmaceutical Products R&D LLC1 trial

Running trials

• Recruiting

  PRA-216 Atopic Dermatitis Safety and Efficacy Study

  NCT07810777· Phase 2· Prana Therapies Inc· Source

  Contact: Claudette Lionnet, MD

• Active, not recruiting

  A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo

  NCT06905873· Phase 1· Forte Biosciences, Inc.· Source

• Active, not recruiting

  A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

  NCT06052267· Phase 3· Teva Branded Pharmaceutical Products R&D LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atopic dermatitis (eczema)1 recruiting

Closed trials

• Completed

  Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis

  NCT06723405· Phase 2· Evommune, Inc.· Source

• Completed

  Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet

  NCT04530123· Phase 2· Takeda· Source